Showing results (741-750 of 784) with videos related to

Sort By:
Pageof 79
Neuro-Oncology|January 18, 2024
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastomaMekenzie M Peshoff, Pravesh Gupta, Shivangi Oberai, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 30, 2019
The natural history of infantile mitochondrial DNA depletion syndrome due to RRM2B deficiencyNandaki Keshavan, Jose Abdenur, Glenn Anderson, et al.
Journal of Medicinal Chemistry|November 29, 2014
Discovery of cytotoxic dolastatin 10 analogues with N-terminal modificationsAndreas Maderna, Matthew Doroski, Chakrapani Subramanyam, et al.
Journal of Medicinal Chemistry|May 21, 2010
Design of selective, ATP-competitive inhibitors of AktKevin D Freeman-Cook, Christopher Autry, Gary Borzillo, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2017
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IVMark J Mitton-Fry, Steven J Brickner, Judith C Hamel, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Optimization of Tubulysin Antibody-Drug Conjugates: A Case Study in Addressing ADC MetabolismL Nathan Tumey, Carolyn A Leverett, Beth Vetelino, et al.
Molecular Genetics and Metabolism Reports|December 6, 2023
Liver transplantation in ornithine transcarbamylase deficiency: A retrospective multicentre cohort studyBerna Seker Yilmaz, Julien Baruteau, Anupam Chakrapani, et al.
Journal of Medicinal Chemistry|January 17, 2014
Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Pageof 79